Hear from experts on some of the most pressing topics in the precision medicine industry today.
Inside NASH: Exploring detection, treatment, and future directions
Join host Dr. Patrick Short for an insightful webinar with Dr. Dimitar Tonev. This session provides valuable details into the evolving landscape of Nonalcoholic Steatohepatitis (NASH), including diagnosis, treatment breakthroughs, and future directions.
Genetics essentials for clinical research professionals
Join host Dr. Patrick Short as he discusses the essentials of genetics and genomics, including genetic variation, genetic testing, and more.
International perspectives on genetic testing in ALS
Join host Dr. Paul Wicks in discussion with Ammar Al-Chalabi, PhD, Kristiana Salmon, and Dr. Patrick Short about global genetic testing for ALS.
Representation matters: Why equitable access and community engagement are critical in genetic research
Join host Lindsey Wahlstrom-Edwards, MPH in discussion with Natasha Ratcliffe, Ebony Scott, and Del Smith, PhD, on the techniques used by industry-leading patient advocacy groups to make research more diverse and representative.
Does the age of onset in SOD1-mediated ALS affect the speed of progression?
Join host Dr. Paul Wicks and Dr. Sarah Opie-Martin as they discuss the latest research on SOD1 gene variants and their association with ALS.
The technical challenges of biomarker-based pre-screening
Join host Dr. Patrick Short in an informative conversation with William Jones, about the technical complexities of managing comprehensive pre-screening programs that encompass biomarkers, patient-reported outcomes, and medical records.
Overcoming the challenges of decentralised clinical trials
Join host Dr. Paul Wicks in conversation with Craig Lipset and Liam Eves focussed on some of the major challenges of decentralised and hybrid clinical trials, solutions to overcome them, and some practical examples.
Patient engagement in precision medicine research
Join host Dr. Paul Wicks in a discussion with Jillian Hastings Ward, Rebecca Middleton, and John Wilbanks. The discussion focussed how patients can be more involved in precision medicine research, as well as how design systems can impact engagement.
Connecting for success: The power of purposeful participant engagement
Join Sano team members Ross Rounsevell and George Bowley as they explore how new technology can help simplify patient engagement processes.
Genetic testing 201: Considerations and next steps for sharing your results
Join host Dr. Patrick Short and guests Krista Qualmann and Jessi Keavney in conversation about how and when to share genetic testing results.
The genetics of NAFLD and NASH
Join host Lindsey Wahlstrom-Edwards, MPH, with guests Wayne Eskridge and Neeraj Mistry in a discussion about the genetics of liver disease and how Sano and the Fatty Liver Foundation are working together to accelerate precision medicine in this area.
An insider’s view on
drug development in NASH
with Dimitar Tonev
Join host Dr. Patrick Short in conversation with Dr. Dimitar Tonev about the NASH therapy landscape, the importance of genetics in trial recruitment, and the controversial topics that should be addressed to bring real improvements to NASH patients.
Opportunities in improving recruitment in decentralized clinical trials
Join host Dr. Patrick Short in conversation with Joss Warren on developing collaborative solutions with industry leading technologies and services that integrate with decentralised clinical trial platforms.
How patient organizations can support innovation and keep their community's health information safe
Join host Dr. Patrick Short in conversation with Lindsey Wahlstrom-Edwards about the impact of genetics on personalised medicine and the vital importance of data security and patient ownership.
Non-invasive screening and genomics in NAFLD with the Fatty Liver Foundation
Join host Dr. Patrick Short with guests Wayne Eskridge and Neeraj Mistry in a discussion about early detection in non-alcoholic fatty liver disease (NAFLD) and NASH using genetics, non-invasive liver testing, and other new technologies.
Meaningful technology, Genomics England
Join host Dr. Paul Wicks in a conversation with Jillian Hastings Ward, Rahki Rajani, and Dr. Patrick Short. The discussion focussed on what taking a participant-centric approach can mean for organisations supporting research.
Participant diversity: Increasing the impact of biomedical research
Join host Dr. Patrick Short with guests Mavis Machirori, Charles Steward, and Jessica Mai Sims as they discuss the topic of participant diversity in biomedical research.
Beyond the genome: Ethical and regulatory landscapes in precision medicine
Join Sarah Howard, Sano's Head of Quality and Regulatory, as she discusses the regulatory landscape, ethical considerations, and data management and privacy in precision medicine trials.
Precision medicine research in Multiple Sclerosis: What is on the horizon?
Join host Dr. Patrick Short in a conversation with Dr. Mark Kotter about the future of precision medicine treatments for Multiple Sclerosis.
How can applying a ‘rare disease mindset’ accelerate and de-risk precision medicine trials?
Join host Dr. Patrick Short and Patti Engel as they discuss lessons from a success story in running a proactive patient finding programme that combined HCP outreach, direct-to-patient outreach, free next-generation DNA sequencing, and a decentralised trial design.
Get in touch
We’ll respond to you within one working day
Want to see more?
Delve into the details of our work with reports on condition areas, industry trends, and more.
Gain insights into the current landscape of precision medicine and clinical research.
Tune in to the leading genetics podcast for hot topics in biomarker-led drug development.